What is STXS's market cap?

$95.91M, based on the Nov 4 close of $0.96.

Does Stereotaxis pay a dividend?

No regular cash dividend has been paid in the last year.

How much of STXS is sold short?

6.0M shares, 8.4% of float, as of Oct 15, 2026.

What sector is STXS in?

Healthcare, in the Electromedical Equipment industry.

NYSE American · STXSHealthcareElectromedical Equipment

Stereotaxis, Inc. Common Stock (STXS)

$0.9572+13.55%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$0.97▼ 64.93% in range

Nov 3, 2025Low $0.84 · High $2.85Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Stereotaxis closed at $0.96 on Nov 4, up 13.55%, 66.4% below its 52-week closing high. Volume of 1.3M shares was 1.90× its 20-day average (above normal).

Split-adjusted performance: -16.8% over one month, -50.1% over six months, -65.6% over one year.

In the quarter ended Jun 30, 2026, revenue was $7.67M, down 12.8% from a year earlier, with a net margin of -62.3%.

Short interest was 6.0M shares at the Oct 15 settlement, up 5.5% from the prior report (8.4% of float, 10.2 days to cover).

Market cap$95.9M100.2M shares

Revenue · quarter$7.7M−12.8% YoY

Diluted EPS$-0.05—

P/E · TTM—P/S 3.2×

Net margin-62.3%Gross 58.5%

Dividend yieldNone

52-week range0.84 – 2.85−66.4% from high

Volume1.3M1.90× 20-day avg

Volatility · 60d50.8%Annualised

Short % of float8.4%10.2 days to cover

Net cash$10.5MCash $10.5M

Next earnings—Not scheduled

Split-adjusted performance

1W −1.4%1M −16.8%3M −29.6%6M −50.1%YTD −58.4%1Y −65.6%3Y −34.9%5Y −83.4%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Electromedical Equipment

Percentile among 22 companies (100 = best)

6-month momentum24

Revenue growth6

Net margin42

Value (low P/E)—

Size52

Industry medians: 6-month return −0.9%, revenue growth +13.9%, net margin −44.6%, P/E 23.7×.

Short interest

Details →

Shares short6.0M+5.5% vs prior

Days to cover10.2Settled Oct 15

% of float8.4%

Short vol. 10d49.7%of daily volume

Closest peers by size in Electromedical Equipment

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
STXSStereotaxis	$0.9572	+13.55%	−50.1%	−12.8%	−62.3%	—	$95.9M
VANIVivani Medical, Inc. Common Stock (DE)	$1.07	+1.90%	−14.4%	—	—	—	$96.5M	Compare
NRXSNeuraxis	$6.86	+4.26%	−22.1%	+115.7%	−118.1%	—	$86.1M	Compare
OMOutset Medical	$4.44	+6.99%	−1.6%	+0.7%	−56.8%	—	$83.5M	Compare
HYPRHyperfine	$0.7503	+8.36%	−56.6%	+44.8%	−238.2%	—	$79.6M	Compare
ECORelectroCore	$8.40	+16.18%	+26.1%	+28.0%	−32.4%	—	$75.7M	Compare
POCIPrecision Optics	$4.84	+3.42%	+2.8%	+42.0%	−1.2%	—	$53.2M	Compare
STEXStreamex	$0.3610	−5.00%	−64.3%	—	−9968.5%	—	$42.0M	Compare
ELMDElectromed	$28.01	+4.83%	+8.0%	+11.6%	17.5%	20.5	$232.1M	Compare

News about Stereotaxis

All news →

Stereotaxis Eyes Billions In Market Opportunity With Robocath TakeoverBenzinga · Apr 15, 2026▲ Positive Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026GlobeNewswire Inc. · Feb 12, 2026Neutral

Quick answers

What does Stereotaxis do?: Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory.
What is STXS's market cap?: $95.91M, based on the Nov 4 close of $0.96.
Does Stereotaxis pay a dividend?: No regular cash dividend has been paid in the last year.
How much of STXS is sold short?: 6.0M shares, 8.4% of float, as of Oct 15, 2026.
What sector is STXS in?: Healthcare, in the Electromedical Equipment industry.

About Stereotaxis

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

HQ: St.Louis, MO131 employeesListed Aug 12, 2004stereotaxis.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology